Protara Therapeutics, Inc.
Records under this name other than the patents Protara Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Protara Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,501,449 | Recombinant elastase proteins and methods of manufacturing and use thereof Lapsed on the fee record Ended Aug 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | From the USPTO record |
| US 8,337,836 | Methods for the treatment and prevention of diseases of biological conduits Term ended Term ended Jun 22, 2024 · From the USPTO record | Term ended | Term ended Jun 22, 2024 | From the USPTO record |
| US 9,057,060 | Recombinant elastase proteins and methods of manufacturing and use thereof Lapsed on the fee record Ended Jun 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 16, 2023 | From the USPTO record |
| US 10,308,924 | Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins Lapsed on the fee record Ended Jun 4, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 4, 2023 | From the USPTO record |
| US 10,301,612 | Recombinant elastase proteins and methods of manufacturing and use thereof Lapsed on the fee record Ended May 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 28, 2023 | From the USPTO record |
| US 7,153,505 | Methods for enlarging the diameter of an artery or vein in a human subject Term ended Term ended Nov 2, 2020 · From the USPTO record | Term ended | Term ended Nov 2, 2020 | From the USPTO record |
| US 7,063,838 | Methods for treating an artery or vein in a human subject Term ended Term ended Sep 24, 2020 · From the USPTO record | Term ended | Term ended Sep 24, 2020 | From the USPTO record |
| US 7,632,494 | Methods for enlarging the diameter of a biological conduit in a human subject Term ended Ended no later than Sep 24, 2020 · From the USPTO record | Term ended | Ended no later than Sep 24, 2020 | From the USPTO record |
| US 7,883,699 | Methods for enlarging the lumen of an obstructed biological conduit Term ended Ended no later than Sep 24, 2020 · From the USPTO record | Term ended | Ended no later than Sep 24, 2020 | From the USPTO record |
| US 8,524,226 | Methods of prolonging patency of hemodialysis access Term ended Term ended Sep 24, 2020 · From the USPTO record | Term ended | Term ended Sep 24, 2020 | From the USPTO record |